← Back to feedRead original →
VERIFIEDMint Markets·positive
Gland Pharma Q1 Results: Net profit jumps 47% YoY to ₹317 crore; CDMO revenue rises 20%
AI Summary
- ·Gland Pharma reported a 47% year-on-year increase in net profit for Q1 FY27, reaching ₹317 crore.
- ·The company's revenue grew 20% year-on-year to ₹1,800 crore.
- ·Revenue growth was primarily fueled by the CDMO and B2B segments, with significant contributions from the US and European markets.